Skip to Content

NAT 123 (Rizatriptan Benzoate 5 mg (base))

Pill with imprint NAT 123 is Pink, Capsule-shape and has been identified as Rizatriptan Benzoate 5 mg (base). It is supplied by Breckenridge Pharmaceutical, Inc..

Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for NAT 123

Rizatriptan benzoate 5 mg (base) NAT 123

Rizatriptan Benzoate

Imprint
NAT 123
Strength
5 mg (base)
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antimigraine agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0354

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.